Forma Therapeutics Reveals $25 Million in Venture Funding, Including Singapore’s Bio*One Capital
This article was originally published in PharmAsia News
Executive Summary
Forma Therapeutics, a Cambridge, Mass.-based start-up with research operations in Singapore, Beijing and Connecticut announced Jan. 6 it raised $25 million in venture capital funding from multiple sources, including Bio*One Capital - Singapore government's biotech investment arm - and the Novartis Option Fund